Your session is about to expire
← Back to Search
Meditation App for Emotion Regulation in Youth on Probation (ProjectAIM Trial)
N/A
Recruiting
Led By Ashley D Kendall, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
13-18 years old
Be younger than 65 years old
Must not have
Are detained
Do not speak English, due to norming of instruments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-month follow-up, 6-month follow-up
Awards & highlights
Summary
This trial tests if a mindfulness intervention delivered via smartphone app can help justice-involved youth on probation regulate their emotions and make healthier choices regarding alcohol use, drug use, sex, and aggression.
Who is the study for?
This trial is for justice-involved youth aged 13-18 on probation in Chicago's Cook County. Participants must understand consent procedures, speak English, have a legal guardian's permission if under 18, agree to participate, and own an Apple or Android phone. Those detained or in DCFS care are excluded.
What is being tested?
The study compares two groups: one uses the Bodhi AIM meditation app (intervention group) and the other does not (control group). It aims to see if the app helps with emotion control and reduces risky behaviors related to HIV/STI like alcohol/cannabis use, sexual activity, and aggression.
What are the potential side effects?
Since this trial involves using a meditation app rather than medication, there aren't typical side effects. However, participants may experience discomfort when discussing personal topics or increased awareness of emotions during mindfulness practice.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 13 and 18 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently detained.
Select...
I do not speak English.
Select...
My legal guardian has not given permission for me to join if I'm under 18.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1-month follow-up, 6-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-month follow-up, 6-month follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in Aggression
Changes in Alcohol Use
Changes in Cannabis Use
+2 moreSecondary study objectives
App Usage
Changes in Additional Facets of Aggression
Changes in Alcohol Trouble
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Bodhi AIMExperimental Treatment1 Intervention
Participants randomized to the intervention group will receive the Bodhi AIM app
Group II: HIBActive Control1 Intervention
Participants randomized to the health promotion control group will receive the HIB app
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,543 Previous Clinical Trials
3,249,176 Total Patients Enrolled
2 Trials studying Aggression
5,593 Patients Enrolled for Aggression
University of Illinois at ChicagoLead Sponsor
632 Previous Clinical Trials
1,567,515 Total Patients Enrolled
Ashley D Kendall, PhDPrincipal InvestigatorUniversity of Illinois at Chicago
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently detained.I am between 13 and 18 years old.I do not speak English.My legal guardian has not given permission for me to join if I'm under 18.
Research Study Groups:
This trial has the following groups:- Group 1: Bodhi AIM
- Group 2: HIB
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger